HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Andreatini Selected Research

Oxidopamine (6 Hydroxydopamine)

1/2021Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.
8/2019PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson's disease.
1/2018Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: Therapeutic implications for Parkinson's disease.
2/2014Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
8/2010Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Andreatini Research Topics

Disease

15Parkinson Disease (Parkinson's Disease)
01/2021 - 04/2002
11Mania (Manias)
01/2021 - 12/2008
7Anhedonia
01/2022 - 08/2010
5Bipolar Disorder (Manic Depressive Psychosis)
02/2017 - 06/2007
5Anxiety Disorders (Anxiety Disorder)
10/2015 - 11/2002
4Panic Disorder (Panic Attack)
01/2020 - 03/2003
3Pain (Aches)
01/2022 - 11/2019
3Sleep Deprivation
10/2019 - 02/2012
2Inflammation (Inflammations)
01/2022 - 03/2012
2Substance-Related Disorders (Drug Abuse)
01/2018 - 01/2009
2Cognitive Dysfunction
01/2011 - 04/2007
2Catalepsy
10/2005 - 04/2002
1Hypertrophy
01/2022
1Hyperalgesia
12/2020
1Fatigue
04/2018
1Shock
10/2017
1Breast Neoplasms (Breast Cancer)
10/2016
1Psychotic Disorders (Schizoaffective Disorder)
07/2014
1Weight Gain
01/2014
1Anosmia
05/2013
1Serotonin Syndrome (Syndrome, Serotonin)
05/2013
1Cocaine-Related Disorders (Cocaine Addiction)
04/2012
1Sleep Initiation and Maintenance Disorders (Insomnia)
03/2012
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2012
1Seizures (Absence Seizure)
01/2011
1Mental Disorders (Mental Disorder)
10/2010
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
10/2010

Drug/Important Bio-Agent (IBA)

7Antidepressive Agents (Antidepressants)IBA
01/2022 - 03/2003
6Pharmaceutical PreparationsIBA
01/2018 - 03/2003
5Oxidopamine (6 Hydroxydopamine)IBA
01/2021 - 08/2010
51- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2011 - 01/2004
4KetamineFDA LinkGeneric
01/2021 - 12/2016
4Sucrose (Saccharose)IBA
01/2021 - 10/2017
4LithiumIBA
10/2019 - 02/2012
4Reserpine (Serpasil)FDA Link
10/2018 - 04/2002
4Methylphenidate (Ritalin)FDA LinkGeneric
02/2017 - 01/2011
4TamoxifenFDA LinkGeneric
10/2016 - 12/2008
4Anti-Anxiety Agents (Anxiolytics)IBA
10/2015 - 03/2003
3Protein Kinase CIBA
02/2017 - 02/2012
3Anticonvulsants (Antiepileptic Drugs)IBA
04/2016 - 06/2007
3RotenoneIBA
12/2014 - 08/2010
3NeurotoxinsIBA
02/2014 - 10/2005
2Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2022 - 04/2007
2myricitrinIBA
01/2022 - 07/2014
2Formaldehyde (Formol)FDA Link
12/2020 - 11/2019
2Pioglitazone (Actos)FDA Link
08/2019 - 01/2011
2AntioxidantsIBA
04/2018 - 02/2017
2Imipramine (Janimine)FDA LinkGeneric
01/2018 - 10/2017
2Antimanic AgentsIBA
04/2016 - 01/2011
2Valproic Acid (Depakote)FDA LinkGeneric
04/2016 - 01/2011
2Amphetamine (Amfetamine)FDA LinkGeneric
07/2014 - 12/2008
2Neurotransmitter Agents (Neurotransmitter)IBA
02/2014 - 08/2010
2Serotonin (5 Hydroxytryptamine)IBA
02/2014 - 08/2010
2lavender oilIBA
05/2013 - 05/2013
2Dopamine (Intropin)FDA LinkGeneric
08/2010 - 01/2009
1Interleukin-6 (Interleukin 6)IBA
01/2022
1andrographolideIBA
01/2021
1Morphine (MS Contin)FDA LinkGeneric
12/2020
1salicylhydroxamic acid (SHAM)IBA
12/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2019
1Amantadine (Aman)FDA LinkGeneric
10/2018
1arabanIBA
04/2018
1CarbohydratesIBA
04/2018
1PectinsIBA
04/2018
1Polysaccharides (Glycans)IBA
04/2018
1BenzodiazepinesIBA
01/2018
1CannabidiolIBA
10/2017
1CorticosteroneIBA
10/2017
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2017
1Proteins (Proteins, Gene)FDA Link
10/2017
1QuercetinIBA
02/2017
1FlavonoidsIBA
02/2017
1Dextroamphetamine (Dexedrine)FDA LinkGeneric
12/2016
1Lisdexamfetamine DimesylateFDA Link
12/2016
1carvoneIBA
04/2016
1Voltage-Gated Sodium ChannelsIBA
04/2016
1Hypnotics and Sedatives (Sedatives)IBA
04/2016
1Carbamazepine (Tegretol)FDA LinkGeneric
04/2016
1Volatile Oils (Essential Oils)IBA
10/2015
1MelatoninIBA
12/2014
1Streptozocin (Streptozotocin)FDA Link
01/2014
1Blood Glucose (Blood Sugar)IBA
01/2014
1ZincIBA
05/2013
1Acetates (Acetic Acid Esters)FDA Link
05/2013
1Fluoxetine (Prozac)FDA LinkGeneric
05/2013
15-Hydroxytryptophan (5 Hydroxytryptophan)IBA
05/2013
18-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
05/2013
15-HT1A Serotonin ReceptorIBA
05/2013
1Dopamine Receptors (Dopamine Receptor)IBA
04/2012
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
03/2012
1Clomiphene (Clomifene)FDA LinkGeneric
08/2011
1Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
01/2011
1Plant ExtractsIBA
12/2010
1GlucocorticoidsIBA
10/2010
1MedroxyprogesteroneIBA
12/2008
1chelerythrineIBA
12/2008
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
12/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
10/2016 - 04/2012
2Therapeutics
07/2014 - 02/2012
1Traditional Medicine (Folk Remedies)
03/2012